n-terminal hemoglobin adduct levels of acrylamide and its genotoxic metabolite, glycidamide in red blood cells were analyzed (by lc/ms/ms) as biomarkers of exposure on 374 breast cancer cases and 374 controls from a cohort of postmenopausal women.